Funding Circle’s disappointing debut doesn’t mean all alternative lending platforms are overhyped. David C Stevenson highlights three of the sector’s wide range of operators.
Alternative finance is the 21st century internet alternative to traditional banks. It includes peer to peer (P2P) lending and crowdfunding. There are plenty of opportunities for smart investors to profit. And while it may carry more risk than some other forms of investing, the potential returns are huge.
There are many different platforms to choose from when deciding where to put your money. Find out which best suits your investment style with our Funding Centre comparison tool.
All alternative finance articles
This mature alternative-finance property firm is not without risks, says David Stevenson, but could still be worth tucking away for the long term.
Every day we all hand over vast amounts of personal data to big business. Why not make a bit of money yourself from the deal?
Investors are spoilt for choice when it comes to robo-advisers – also known as digital wealth managers. David Stevenson looks at what’s available, and how they differ.
An auction house in France stoked controversy last month with the sale of a fossilised dinosaur skeleton. Chris Carter reports.
Punks, kitties and virtual tulips: the technology underlying cryptocurrencies has created a whole new world of digital art
The City is missing a trick, says Matthew Lynn. London is the natural home for the growing cryptocurrency industry.
Ed Bowsher has been using equity-crowdfunding platforms to invest in small businesses and start-ups since 2012. Here’s what he’s learned so far.
Peer-to-peer lenders are waking up to the potential of providing finance for social housing. David Stevenson explores two new offerings.
Exo Investing can help you eliminate the natural behavioural biases that are deeply ingrained in the human brain, and which can cost you dear when making investment decisions.
A new equity crowdfunding platform wants to become the go-to place for investors in early-stage life science companies.